Gojicort Tablet is a corticosteroid formulation known for its immunomodulatory and anti-inflammatory properties. It is widely used in clinical practice where physicians determine that controlled corticosteroid support is appropriate for managing various inflammatory, allergic, or immune-related conditions. The formulation provides a reliable option for situations in which modulation of the body’s inflammatory response is essential for patient comfort and overall clinical management. Deflazacort is a synthetic glucocorticoid that exerts its effect by influencing the activity of inflammatory mediators and reducing the body’s natural immune response in targeted conditions. It is recognized for offering therapeutic benefits comparable to other corticosteroids while being noted in many cases for a favourable tolerability profile. This makes it a preferred choice for long-term treatment plans or chronic conditions when directed by a healthcare professional. The 6 mg strength is commonly selected to allow flexible dosing adjustments based on individual clinical needs, helping physicians tailor treatment precision and support optimal outcomes. The tablet is designed for convenient oral administration and consistent absorption, ensuring predictable systemic availability and therapeutic effect. Its formulation supports stable pharmacokinetics, enabling healthcare providers to manage gradual dose titration or tapering when required. Deflazacort is often incorporated into treatment strategies for conditions involving inflammation, autoimmune activity, or hypersensitivity reactions. Its use is guided by professional judgement, taking into consideration patient history, disease severity, and potential interaction with concurrent therapies. As with all corticosteroid-containing medications, responsible use under medical supervision is essential. Regular monitoring, adherence to prescribed duration, and awareness of potential side effects help ensure safety and effectiveness. Patients are encouraged to follow their healthcare provider’s recommendations closely and avoid abrupt discontinuation unless medically advised.
| Packing | 10*10 (A/A) |
| GST | 5% |